S100B Antibodies

S100B is a protein belonging to the S100 family of calcium-binding proteins. It has a molecular weight of approximately 21 kDa and is primarily expressed in the central nervous system, specifically in astrocytes, which are a type of glial cell in the brain. This protein functions as a calcium sensor and is involved in various cellular processes, including regulation of cell cycle progression, cell differentiation, and intracellular signaling.

Elevated levels of S100B in the blood or cerebrospinal fluid are associated with various neurological conditions, including traumatic brain injury, stroke, and neurodegenerative diseases. It has been studied as a biomarker for brain injury and as a potential indicator of the severity of neurological damage.

Antibodies against S100B are commonly used in research to detect and quantify its levels in tissues or biological fluids. In diagnostics,  measurements are utilized to assess the extent of brain injury or neurological conditions, particularly in the context of traumatic brain injury. In some cases, elevated levels in blood samples may prompt further diagnostic imaging or interventions.

Synonyms

Protein S100-B, NEF|S100|S100-B|S100beta

Research Areas

Apoptosis, Autophagy, Breast Cancer, Cancer, Cardiovascular, Cell Biology, Cellular Markers and Tags, Developmental Biology, Endocrine, Epigenetics, Gastrointestinal Tract, Hypoxia, Immuno Oncology, Immunology, Kidney, Lymphatic, Metabolism, Microbiology, Muscle, Neuroscience, Pancreatic Cancer, Prostate Cancer, Skin, Stem Cell, AKT Signaling, Angiogenesis, Articular Cartilage Extracellular Matrix, B Cell Markers, Basal Cell Marker, BBB VCAM-1 Signaling, Bladder Cancer, Cardiac Stem Cells, Colon Cancer, Colorectal Cancer, Complement System, CTLA-4 blockade immunotherapy, Cytokine Signaling, Defective Intrinsic Apoptosis, Dendritic Cell Marker, Digestion, Endothelial Cell Marker, Hematopoietic Stem Cells, Immune checkpoint, Infectious Disease, Lipid Metabolism, Lung Cancer, MAPK Signaling, Mast Cell Marker, Melanoma, Mesenchymal Stem Cell Differentiation, Mitochondria Marker, Neural Stem Cells, Neuroinflammation, Nuclear Marker, Oncology, Ovarian Cancer, PD-1 blockade immunotherapy, Signal Transduction, Stem Cell Differentiation, Transcription Factors

S100B

PARTNERSHIP OPPORTUNITIES

NeoBiotechnologies holds Exclusive rights to 10,000 recombinant and hybridoma antibody products, available for Licensing or Collaboration.

LETS TALK